Perfil
Kari Myren is currently Chief Medical Officer at Oncoinvent ASA since 2021.
Former positions include Non-Executive Director at SoftOx Solutions AS, VP-Global Medical Affairs & Clinical Development at Photocure ASA from 2019 to 2021, and Chief Medical Officer at Oncoinvent ASA (Old).
Education includes an undergraduate degree from the University of Oslo.
Cargos activos de Kari Myren
| Empresas | Cargo | Inicio |
|---|---|---|
| ONCOINVENT ASA | Director Técnico/Científico/I+D | 01/01/2021 |
Antiguos cargos conocidos de Kari Myren.
| Empresas | Cargo | Fin |
|---|---|---|
| SOFTOX SOLUTIONS | Director/Miembro de la Junta | 24/03/2023 |
| PHOTOCURE ASA | Director Técnico/Científico/I+D | 01/10/2021 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Director Técnico/Científico/I+D | - |
Formación de Kari Myren.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Photocure ASA
Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
SoftOx Solutions AS
SoftOx Solutions AS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures non-toxic & antiseptic medicines | Commercial Services |
- Bolsa de valores
- Insiders
- Kari Myren
















